We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TMCI market cap is 332.72M. The company's latest EPS is USD -0.7964 and P/E is -6.68.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41.95M | 40.76M | 62.21M | 51.11M | 44.46M |
| Operating Income | -13.05M | -17.82M | -6.78M | -18.97M | -21.38M |
| Net Income | -12.27M | -17.52M | -6.28M | -18.68M | -21.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 39.42M | 57.37M | 94.42M | 141.84M | 187.12M |
| Operating Income | -3.54M | 855k | -16.51M | -34.84M | -51.43M |
| Net Income | -4.91M | -4.31M | -20.75M | -42.82M | -49.53M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 249.64M | 240.36M | 251.91M | 242.73M | 226.08M |
| Total Liabilities | 99.68M | 102.5M | 113.97M | 116.34M | 113.94M |
| Total Equity | 149.96M | 137.86M | 137.94M | 126.39M | 112.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 29.72M | 41.81M | 140.82M | 159.02M | 251.91M |
| Total Liabilities | 26.56M | 41.03M | 47.75M | 98.5M | 113.97M |
| Total Equity | 3.16M | 776k | 93.07M | 60.53M | 137.94M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.59M | -35.11M | -34.58M | -7.22M | -21.12M |
| Investing | -90.9M | -86.31M | -81.3M | 3.76M | 26.19M |
| Financing | 109.06M | 109.22M | 109.38M | -185k | 126k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.67M | -4.49M | -17.19M | -30.65M | -34.58M |
| Investing | -1.21M | -1.07M | -2.71M | -76.52M | -81.3M |
| Financing | 19.74M | 11.5M | 107.65M | 20.81M | 109.38M |
| Market Cap | 332.72M |
| Price to Earnings Ratio | -6.68 |
| Price to Sales Ratio | 1.77 |
| Price to Cash Ratio | 25.49 |
| Price to Book Ratio | 2.4 |
| Dividend Yield | - |
| Shares Outstanding | 62.19M |
| Average Volume (1 week) | 567.97k |
| Average Volume (1 Month) | 408.22k |
| 52 Week Change | -52.02% |
| 52 Week High | 15.98 |
| 52 Week Low | 3.92 |
| Spread (Intraday) | 0.02 (0.37%) |
| Company Name | Treace Medical Concepts Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.treace.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
